Rituximab therapy of recalcitrant bullous dermatoses

Journal of Dermatological Case Reports

Uwe Wollina¹  André Koch¹  Gesina Hansel¹ 

[1]Department of Dermatology and Allergology, Hospital Dresden-Friedrichstadt, Academic Teaching Hospital of the Technical University of Dresden, Friedrichstrasse 41, 01067 Dresden, Germany

关键词: monoclonal antibody;    rituximab;    bullous pemphigoid;    mucous membrane pemphigoid;    pemphigus vulgaris;   

DOI  :  10.3315/jdcr.2008.1007

学科分类：皮肤病学

来源: Specjalisci Dermatolodz

【 摘 要 】

Rituximab is a monoclonal antibody directed against CD20 cell surface antigen of B-lymphocytes. Recent studies have demonstrated effectivity in recalcitrant bullous pemphigoid. The data available on other types of autoimmune bullous disease is more scant.

【 授权许可】

Unknown